Neuroblastoma On-line Researcher's Forum

Recent Publications About Neuroblastoma


This page is intended for physicians and research scientists.

ISSUE: 1999/11/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers
References: Basic Science / Research
Previous Issue of Recent Publications (1999/10/a)
Next Issue of Recent Publications (1999/11/b)
Back to NBL-PROF Home Page

Clinical / Prognostic Markers

[Conference Review] Report of the 1998 Consensus Conference on Neuroblastoma Screening. Med Pediatr Oncol. 1999 Oct;33(4):357-9.    [Related articles]
+See also: Screening

Somjee S, et al. Metastatic ovarian neuroblastoma: a case report. Pediatr Hematol Oncol. 1999 Sep-Oct;16(5):459-62.    [Related articles]

Philip T. Early detection of neuroblastoma in infants: Research? Yes. Routine Screening? No. Med Pediatr Oncol. 1999 Oct;33(4):355-6.    [Related articles]
+See also: Screening

Palasis S, et al. Central nervous system relapse following bone marrow transplantation in stage IV neuroblastoma. Pediatr Hematol Oncol. 1999 Sep-Oct;16(5):443-52.    [Related articles]

Ohyama M, et al. Congenital neuroblastoma diagnosed by placental examination. Med Pediatr Oncol. 1999 Oct;33(4):430-1.    [Related articles]

Muller-Berghaus J, et al. Artificial abdominal hernia for the treatment of hepatomegaly in a neonate with stage 4S neuroblastoma. Pediatr Hematol Oncol. 1999 Sep-Oct;16(5):453-8.    [Related articles]

McHugh K, et al. Bilateral ovarian involvement at presentation in metastatic (stage 4) neuroblastoma. Pediatr Radiol. 1999 Oct;29(10):741.    [Related articles]

Matthay KK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999 Oct 14;341(16):1165-73.    [Related articles]
+See also: Trials & Studies

Kushner BH, et al. Oral Etoposide for Refractory and Relapsed Neuroblastoma. J Clin Oncol. 1999 Oct;17(10):3221-3225.    [Related articles]

Kawa K, et al. Long-Term Survivors of Advanced Neuroblastoma With MYCN Amplification: A Report of 19 Patients Surviving Disease-Free for More Than 66 Months. J Clin Oncol. 1999 Oct;17(10):3216-3220.    [Related articles]
+See also: MYCN Amplification

Kato K, et al. Metachronous renal cell carcinoma in a child cured of neuroblastoma. Med Pediatr Oncol. 1999 Oct;33(4):432-3.    [Related articles]

Basic Science / Research

Xiao G, et al. Calreticulin is transported to the surface of NG108-15 cells where it forms surface patches and is partially degraded in an acidic compartment. J Neurosci Res. 1999 Dec 1;58(5):652-662.    [Related articles]

Bernardini S, et al. Modulation of glutathione transferase P1-1 activity by retinoic acid in neuroblastoma cells. J Cell Biochem. 1999 Dec 1;75(3):375-381.    [Related articles]

Tieu K, et al. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement of Bcl-2 and p53 proteins. J Neurosci Res. 1999 Nov 1;58(3):426-435.    [Related articles]

Schumann G, et al. Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells. J Neurochem. 1999 Nov;73(5):2009-17.    [Related articles]

Raggi CC, et al. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Clin Chem. 1999 Nov;45(11):1918-24.    [Related articles]
+See also: MYCN Amplification

Pignatelli M, et al. Involvement of the NGFI-A gene in the differentiation of neuroblastoma cells. FEBS Lett. 1999 Nov 12;461(1-2):37-42.    [Related articles]

Kim CJ, et al. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Am J Pathol. 1999 Nov;155(5):1661-70.    [Related articles]

Cinatl J Jr, et al. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Int J Oncol. 1999 Nov;15(5):1001-1009.    [Related articles]

Young KW, et al. Lysophosphatidic acid-mediated Ca2+ mobilization in human SH-SY5Y neuroblastoma cells is independent of phosphoinositide signalling, but dependent on sphingosine kinase activation. Biochem J. 1999 Oct 1;343(Pt 1):45-52.    [Related articles]

Yoshida H, et al. Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors. Cancer Gene Ther. 1999 Sep-Oct;6(5):395-401.    [Related articles]

Tullio RD, et al. Changes in intracellular localization of calpastatin during calpain activation. Biochem J. 1999 Oct 15;343(Pt 2):467-472.    [Related articles]

Spampinato S, et al. Characterization of a putative calcitonin receptor in IMR 32 human neuroblastoma cells. Neurosci Lett. 1999 Oct 8;273(3):167-70.    [Related articles]

Puyo AM, et al. Increased plasma atrial natriuretic factor in catecholamine-producing tumor patients. Clin Exp Hypertens. 1999 Oct;21(7):1129-44.    [Related articles]

Pacheco MA, et al. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res. 1999 Oct 1;72(2):138-46.    [Related articles]

Matsui T, et al. Induction of catecholamine synthesis in human neuroblastoma cells by replication inhibitors and sodium butyrate. Brain Res. 1999 Oct 2;843(1-2):112-117.    [Related articles]

Kumar A, et al. Adenosine 3',5'-cyclic monophosphate increases processing of amyloid precursor protein (APP) to beta-amyloid in neuroblastoma cells without changing APP levels or expression of APP mRNA. Neurochem Res. 1999 Oct;24(10):1209-15.    [Related articles]

Keren O, et al. Potentiation of transmitter release from NMB human neuroblastoma cells by kappa-opioids is mediated by N-type voltage-dependent calcium channels. Brain Res. 1999 Oct 2;843(1-2):193-198.    [Related articles]

Guidarelli A, et al. Different signalling pathways mediate the opposite effects of endogenous versus exogenous nitric oxide on hydroperoxide toxicity in CHP100 neuroblastoma cells. J Neurochem. 1999 Oct;73(4):1667-73.    [Related articles]

Forgeur A, et al. Natriuretic Peptide Receptors of Type A in Human Neuroblastomas. Neuroendocrinology. 1999 Oct;70(4):288-294.    [Related articles]

Feng Z, et al. NF-kappaB/Rel proteins are required for neuronal differentiation of SH-SY5Y neuroblastoma cells. J Biol Chem. 1999 Oct 22;274(43):30341-4.    [Related articles]

Encinas M, et al. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem. 1999 Oct;73(4):1409-21.    [Related articles]

Elmlinger MW, et al. Correlation of type I insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin. Regul Pept. 1999 Oct 22;84(1-3):37-42.    [Related articles]

De Moerloose B, et al. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors. Cytometry. 1999 Oct 1;37(2):125-32.    [Related articles]

Cattaneo MG, et al. Somatostatin inhibits PDGF-stimulated ras activation in human neuroblastoma cells. FEBS Lett. 1999 Oct 1;459(1):64-8.    [Related articles]

Carlson K, et al. Organophosphorus compound-induced modification of SH-SY5Y human neuroblastoma mitochondrial transmembrane potential. Toxicol Appl Pharmacol. 1999 Oct 1;160(1):33-42.    [Related articles]

Ben Arush MW, et al. Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma. Med Pediatr Oncol. 1999 Oct;33(4):418-9.    [Related articles]

Andres MI, et al. Biochemical effects of chlorpromazine on mouse neuroblastoma cells. Vet Hum Toxicol. 1999 Oct;41(5):273-8.    [Related articles]

Lindahl LS, et al. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci. 1999; 50(2):236-43.    [Related articles]

Previous Issue of Recent Publications (1999/10/a)
Next Issue of Recent Publications (1999/11/b)
Back to NBL-PROF Home Page